Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Payables (2023 - 2025)

Fractyl Health (GUTS) has disclosed Payables for 3 consecutive years, with $12.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Payables rose 36.81% year-over-year to $12.4 million, compared with a TTM value of $12.4 million through Sep 2025, up 36.81%, and an annual FY2024 reading of $11.6 million, up 57.95% over the prior year.
  • Payables was $12.4 million for Q3 2025 at Fractyl Health, down from $12.9 million in the prior quarter.
  • Across five years, Payables topped out at $12.9 million in Q2 2025 and bottomed at $7.1 million in Q2 2024.
  • Average Payables over 3 years is $10.2 million, with a median of $10.3 million recorded in 2024.
  • Peak annual rise in Payables hit 81.27% in 2025, while the deepest fall reached 36.81% in 2025.
  • Year by year, Payables stood at $7.3 million in 2023, then skyrocketed by 57.95% to $11.6 million in 2024, then increased by 6.69% to $12.4 million in 2025.
  • Business Quant data shows Payables for GUTS at $12.4 million in Q3 2025, $12.9 million in Q2 2025, and $12.3 million in Q1 2025.